Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Clinical trial NCT06125951 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06125951
Sponsor: Actinogen Medical
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Dementia Moderate Dementia, Mild Alzheimer Disease

Start date: 2024-04-12
Primary completion: 2026-10-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.